N
BSX icon

Nuveen’s Boston Scientific BSX Stock Holding History

Nuveen’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-51,000
Closed -$2K – 3297
2020
Q2 		$2K Hold
51,000
– – ﹤0.01% 3250
2020
Q1 		$2K Buy
+51,000
New +$1.99M ﹤0.01% 3187

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Nuveen's BSX Position: Q1 2026 in Review

Nuveen increased its Boston Scientific (BSX) stake by 25% in Q1 2026, buying an estimated $189M and bringing the position to 11,734,314 shares worth $736M. The position accounts for 0.2% of the portfolio, ranked #96.

Nuveen first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.02B in Q2 2025. 1,671 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Nuveen held 11,734,314 shares of Boston Scientific worth $736M as of Q1 2026.
  • Nuveen bought 2,362,020 Boston Scientific shares in Q1 2026, an estimated $189M.
  • Boston Scientific made up 0.2% of Nuveen's portfolio in Q1 2026, its #96 holding.
  • Nuveen first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
  • Nuveen's Boston Scientific position peaked at $1.02B in Q2 2025.
  • 1,671 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.